AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Technical topics at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

17 organizations at AMP 2026 present work in technical topics: 13 academic medical centres, children's hospitals and universities, 2 agencies, societies and non-profits, 1 clinical laboratory and 1 company. Between them they bring 90 presentations to the program. Most represented: MD Anderson Cancer Center, University of Washington and University of Michigan. As of Nov 12, 2026.

All 321 organizations at AMP 2026 →

Format
Top represented
Showing 1–4 of 17 organizations
OrganizationAMP 2026 Attendance
Med centres
Comprehensive cancer center and academic medical institution in Houston, with clinical molecular diagnostics laboratories.
Workshop
Wed, Nov 11
10:00am–10:50am
Beyond Tissue: Implementing Alternative Analytes for Molecular Diagnostics in Clinical Practice
Using cerebrospinal fluid and fine needle aspirate supernatant for sequencing when tumour tissue is scarce or unavailable.
Workshop hosted by Thermo Fisher Scientific
Workshop
Wed, Nov 11
10:00am–10:50am
Optical Genome Mapping in Hematologic Malignancies: Optimized Workflows to Uniquely Detect Cytogenomic Variants in Hematologic Malignancies
Optical genome mapping workflows for leukemia, and evidence it finds significant structural variants that standard cytogenetics can miss.
Workshop hosted by Bionano Genomics
Workshop
Wed, Nov 11
12:00pm–12:50pm
A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring
Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly.
Workshop hosted by Countable Labs
Workshop
Thu, Nov 12
12:00pm–12:30pm
AMP Practice Guidelines Meet the Authors Series: Lung Guideline Update
New lung cancer molecular testing recommendations from the updated joint practice guideline, with the evidence and process behind them.
Session
Fri, Nov 13
10:15am–11:45am
Workshop
Fri, Nov 13
9:30am–10:00am
Electronic Genome Mapping for Structural Variant Detection: Implications for Advancing Clinical Research in Heme Malignancies
Electronic genome mapping weighed against karyotyping, FISH and optical mapping for structural variants, including marrow versus blood samples.
Workshop hosted by Nabsys
Talk
Sat, Nov 14
10:15am–11:00am
From AI Promise to Clinical Practice: Which Genomic Foundation Models Can You Trust in Molecular Testing?
How well DNA foundation models actually perform on clinical genomic tasks, and how to judge which ones to trust.
Informatics
Talk
Sat, Nov 14
3:00pm–3:30pm
Direct DNA Methylation Analysis by Single Molecule Real-Time Sequencing
A transformer model reads polymerase kinetics from SMRT sequencing to call 5mC, 5hmC and 6mA base modifications directly.
Technical Topics
Med centres
Public research university in Seattle with a genome sciences department and clinical laboratories in genetics and laboratory medicine.
Workshop
Wed, Nov 11
2:00pm–3:50pm
Evaluation of the BioCode® STI + Resistance Panel for STI Detection, Antimicrobial Resistance Markers, and Multiplex STI Panels Reimbursement Considerations
Performance of a multiplex panel detecting chlamydia, gonorrhea, mycoplasma and trichomonas with resistance markers, plus reimbursement.
Workshop hosted by Applied BioCode
Session
Thu, Nov 12
10:15am–11:45am
Clinically Actionable Mutational Signatures in Solid Tumors
Informatics · Solid Tumors
  1. 10:15am–10:45amDetecting Homologous Recombination Deficiency with Genomic and AI-Based ApproachesUniversity of California San Diego
  2. 10:45am–11:15amClinical Utility of Detecting Mismatch Repair Deficiency as a Mutational SignatureBrigham and Women's Hospital
  3. 11:15am–11:45amNovel Mutational Signatures in CancerUniversity of California San Francisco
Talk
Thu, Nov 12
2:30pm–3:00pm
AMP Clinical Validation of cfDNA and ctDNA Assays Working Group
Setting validation standards for liquid biopsy assays in oncology, with attendee input shaping the guideline under development.
Talk
Fri, Nov 13
1:15pm–2:45pm
Beyond Git: Bringing CI/CD to Clinical Bioinformatics
How Git version control and CI/CD pipelines make clinical bioinformatics software reproducible, traceable and ready for regulatory review.
Informatics
Talk
Sat, Nov 14
2:30pm–3:15pm
Beyond the Swab: The Evolution of STI Diagnostics
Sexually transmitted infection testing from culture-era methods to multiplex and point-of-care molecular assays, and what comes next.
Infectious Diseases
Med centres
Public research university and academic medical centre in Ann Arbor with clinical cancer genomics and molecular diagnostics programmes.
Session
Thu, Nov 12
10:15am–11:45am
Technical Advancement in Spatial Genomics and Multi-omics
Solid Tumors · Technical Topics
  1. 10:15am–11:00amSpatial Multi-Omics Profiling in TissuesUniversity of Pennsylvania
  2. 11:00am–11:45amMolecular-Resolution Spatial Inference of Subcellular Transcriptional ProgramsUniversity of Michigan
Talk
Thu, Nov 12
11:00am–11:45am
Molecular-Resolution Spatial Inference of Subcellular Transcriptional Programs
Submicron spatial transcriptomics plus segmentation-free analysis that assigns cell type and transcriptional programs from individual transcripts.
Solid Tumors · Technical Topics
Workshop
Thu, Nov 12
12:40pm–1:10pm
AI in Trainee Education: A Demonstration and Discussion
Building a large language model study aid for pathology trainees, alongside survey findings on how trainees and educators use AI.
Talk
Thu, Nov 12
8:30am–8:45am
Opening Remarks
  1. 8:30am–8:45amOpening Remarks
Talk
Fri, Nov 13
2:00pm–2:45pm
Development and Use of Menin Inhibitors as Precision Medicines for Acute Myeloid Leukemia
Development of menin inhibitors for KMT2A-rearranged and NPM1-mutant acute myeloid leukemia, plus response biomarkers and resistance.
Hematopathology
Med centres
Private research university in California whose medical school runs clinical genomics, molecular pathology and metagenomic sequencing laboratories.
Session
Thu, Nov 12
10:15am–11:45am
Clinically Actionable Mutational Signatures in Solid Tumors
Informatics · Solid Tumors
  1. 10:15am–10:45amDetecting Homologous Recombination Deficiency with Genomic and AI-Based ApproachesUniversity of California San Diego
  2. 10:45am–11:15amClinical Utility of Detecting Mismatch Repair Deficiency as a Mutational SignatureBrigham and Women's Hospital
  3. 11:15am–11:45amNovel Mutational Signatures in CancerUniversity of California San Francisco
Session
Thu, Nov 12
10:15am–11:45am
Computational Analysis of Fragmentation and Methylation Patterns in ctDNA for Early Cancer Detection
Informatics · Technical Topics
  1. 10:15am–11:00amBespoke Cell-free DNA Fragmentation Biomarkers for Early Cancer DetectionSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
  2. 11:00am–11:45amMulti-Omic Single Molecule Profiling of Cell Free DNA Reveals Cancer SignaturesStanford Univeristy
Talk
Thu, Nov 12
11:00am–11:45am
Multi-Omic Single Molecule Profiling of Cell Free DNA Reveals Cancer Signatures
Single-molecule reads of scant cell-free DNA capture methylation, hydroxymethylation and fragmentation to profile cancers and spot brain metastases.
Informatics · Technical Topics
Session
Fri, Nov 13
8:15am–9:15am
Informatics Plenary Session
Informatics
  1. 8:15am–9:15amTransforming Healthcare Using Deep Data and Remote MonitoringStanford University School of Medicine
Session
Sat, Nov 14
10:15am–11:45am
Foundation Models in Molecular
Informatics
  1. 10:15am–11:00amFrom AI Promise to Clinical Practice: Which Genomic Foundation Models Can You Trust in Molecular Testing?The University of Texas MD Anderson Cancer Center
  2. 11:00am–11:45amScoring Variants with Genomic Foundation ModelsGenomics England
Session
Sat, Nov 14
1:45pm–2:15pm
AMP Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working Group
A working-group update on making genomic variant data interoperable in electronic health records, and where standards still fall short.
Talk
Sat, Nov 14
2:45pm–4:00pm
Toward a Paradigm Shift in Personalized Therapies for Lymphoma Using Liquid Biopsies
Circulating tumor DNA in diffuse large B-cell lymphoma for genotyping, early response measurement and residual-disease-guided treatment.
Hematopathology · Technical Topics

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in technical topics

Tell us what you sell and we’ll find the people at organizations working on technical topics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse AMP 2026 by

Exhibit hall

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction